(؊)-Epigallocatechin-3-gallate (EGCG) is an important bioactive constituent of green tea that efficiently reduces epidermal cancer cell proliferation. This inhibition is associated with a reduction in activator protein 1 (AP1) transcription factor level and activity. However, its effects on AP1 function in normal epidermal cells have not been extensively explored. Our present studies show that EGCG regulates normal keratinocyte function. To understand the mechanism of action, we examined the effects of EGCG on AP1 factor activity, MAPK signal transduction, and expression of the AP1 factorregulated human involucrin (hINV) gene. EGCG increases hINV promoter activity in a concentration-dependent manner that requires the presence of an intact hINV promoter AP1 factor binding site. This response appears to be physiologic, as endogenous hINV gene expression is also increased. Fra-1, Fra-2, FosB, JunB, JunD, c-Jun, and c-Fos levels are increased by EGCG treatment, as is AP1 factor binding to hINV promoter AP1 site. Gel mobility shift studies show that this complex contains Fra-1 and JunD. Signal transduction analysis indicates that the EGCG response requires Ras, MEKK1, MEK3, and p38 kinases. Kinase assays and inhibitor studies suggest that p38␦ is the p38 isoform responsible for the regulation. These changes are also associated with a cessation of cell proliferation and enhanced cornified envelope formation. These studies show that in normal human keratinocytes EGCG markedly increases, via a MAPK signaling mechanism, AP1 factor-associated responses.The polyphenol constituents of green tea inhibit carcinogenesis in a variety of tissues (1-4); however, their mechanism of action is not well understood. (Ϫ)-Epigallocatechin-3-gallate (EGCG) 1 is the major polyphenol isolated from green tea. AP1 transcription factors and AP1 factor-associated signal transduction are important targets of EGCG action (5-7). AP1 proteins consist of homodimers of Jun proteins (c-Jun, JunB, and JunD) and heterodimers of Jun and Fos (c-Fos, FosB, Fra-1, and Fra-2) factors (8). These proteins regulate transcription, differentiation, and cell proliferation by binding to specific recognition motifs in target genes (9 -13). EGCG produces specific changes in AP1 factor function in immortalized and transformed keratinocytes. These changes include an EGCGdependent reduction in phorbol ester-dependent mitogen-activated protein kinase (MAPK) activity (6), and reduced AP1 factor level and activity (7,14). EGCG also inhibits ultraviolet light-associated activation of c-Fos gene expression and the accumulation of c-Fos protein (7). Based on these studies, it has been suggested that the cancer-preventive role of EGCG may be due, in part, to its ability to reduce AP1 factor-related responses (6,7,14). However, very little information is available regarding how EGCG effects AP1 factor-regulated responses in normal keratinocytes. Our present studies show that EGCG increases AP1 factor levels in normal keratinocytes, and increases human involucrin gene expressio...